HOME >> MEDICINE >> NEWS
Proposal calls for sweeping changes at US Food and Drug Administration

WINSTON-SALEM, N.C. -- Five current or former members of the Drug Safety and Risk Management Advisory Committee to the U.S. Food and Drug Administration (FDA) called today for Congress to make sweeping changes to deal with a large number of longstanding problems at the agency.

"The current FDA system of regulating drug safety has serious limitations and is in need of changes," they say in Archives of Internal Medicine, released today. Since Congress is ultimately responsible, "it is up to Congress to take the steps necessary to reinvigorate the FDA's ability to assure the public that approved medical products are safe."

Curt D. Furberg, M.D., Ph.D., professor of public health sciences at Wake Forest University School of Medicine and the lead author, said the five decided to write the analysis after becoming discouraged by the FDA's inability to fix its own problems.

"Congress has not provided adequate funding and authority to the FDA," he said.

The group cites eight major problems impacting FDA performance, including:

  • The system of initial approval of drugs often fails to detect serious adverse drug reactions.
  • The same FDA center that approves drugs also has the responsibility of taking safety actions, creating a conflict-of-interest situation.
  • The FDA is overly dependant on user fees from drug companies.
  • The FDA is short on expertise in drug safety and public health.

"The key features of today's media stories about questionable drug safety are the same as with previous drug tragedies," Furberg said. "New drugs are introduced on the market with inadequate safety documentation; serious adverse drug reactions are later reported from the marketplace, and a large number of patients are unnecessarily injured before the drugs are withdrawn or better managed. The only difference is the name of the culprit drug."

Furberg and his colleagues recommend that Congress make five changes:

    '"/>


Contact: Robert Conn
rconn@wfubmc.edu
336-716-4587
Wake Forest University Baptist Medical Center
9-Oct-2006


Page: 1 2

Related medicine news :

1. Report calls for new directions, innovative approaches in testing chemicals for toxicity to humans
2. National Academy of Sciences Institute of Medicine report calls for more dairy foods at school
3. Report calls for using heated chemotherapy after colon cancer surgery to optimize patient survival
4. Civil society movement calls for transparency in the WHO director-general elections
5. Study calls for 39 percent more family physicians
6. The Lancet calls for transparency in the selection of a new executive director for the global fund
7. The Lancet calls on research community to address neglected disease that causes heart failure
8. International AIDS Vaccine Initiative calls for new measures to search for an AIDS vaccine
9. Who calls for stronger collaboration between HIV/AIDS and TB programs in the developing world
10. New data finds recalls of automated external defibrillators to be common
11. World Hypertension League calls for urgent action to get more hypertensive patients to goal

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... in Oakland, California effectively destroyed the construction site and threatened numerous homes and ... July 7th article on NBCLosAngeles.com. Los Angeles Area consulting firm Fire ...
(Date:7/24/2017)... ... ... The International Essential Tremor Foundation (IETF) will host a free educational forum ... will take place on Saturday, Aug. 26 at the Embassy Suites by Hilton Cleveland ... 9 a.m. to 12 p.m., with check-in beginning at 8 a.m. The event is ...
(Date:7/24/2017)... ... ... Axiad IDS , a leading provider of trusted identities for enterprise, ... to expand its solution to help government contractors more quickly and cost-effectively comply with ... address the authentication requirements within NIST SP800-171, but no matter how you address ...
(Date:7/24/2017)... ... July 24, 2017 , ... Independence Blue Cross (Independence) ... an Innovation Collaboration program, have signed a five-year agreement that will marshal resources ... care members and patients receive. The agreement also signifies Jefferson Health officially joining ...
(Date:7/24/2017)... ... July 24, 2017 , ... Puregraft, the ... announces the issuance of United States Patent Number 9,695,398 (the '398 patent) and ... The '398 and '324 patents cover methods and systems for optimizing fat ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
(Date:7/10/2017)... -- The tenth annual BioPharm America™ will take ... the Sheraton Boston Hotel, September 26–27. The event will ... makers and innovative biotech startup companies. The event is ... impactful days. BioPharm America is now part of Biotech ... with 4,500+ life science industry influencers participating in 8+ ...
(Date:7/5/2017)... 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... received approval from the Israel Securities Authority to dual-list its ... common stock will commence trading on the TASE on July ... market capitalization of the Company, it is expected that Oramed ...
Breaking Medicine Technology:
Cached News: